Keywords: COX-2; cyclooxygenase-2; DOCA; deoxycorticosterone acetate; FOX1; ferrous ion oxidation by xylenol orange reagent; FRAP; ferric reducing antioxidant power; H & E; hematoxylin and eosin; H2O2; hydrogen peroxide; IL; interleukin; MDA; malondialdehyde; NADPH
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: WD; Western diet; RAAS; renin angiotensin- aldosterone system; CVD; cardiovascular disease; MR; mineralocorticoid receptor; ECMR; endothelial cell mineralocorticoid receptor; DOCA; deoxycorticosterone acetate; SGK1; serum-and glucocorticoid-regulated ki
Keywords: Cardiovascular diseases; inflammation; prenatal inflammatory exposure; maternal immune activation; developmental reprogramming; NF-κB; ACE; Angiotensin-converting enzyme; ACTH; Adrenocorticotropic hormone; Ang II; Angiotensin II; ApoE; Apolipoprotein E;
Keywords: ANG II; angiotensin II; CeA; central nucleus of amygdala; DOCA; deoxycorticosterone acetate; GPER; G protein-coupled estrogen receptor; LPBN; lateral parabrachial nucleus; LV; lateral ventricle; MR; mineralocorticoid receptors; NTS; nucleus of the solitar
Keywords: AngII; angiotensin II; APCs; antigen presenting cells; Aza; azathioprine; CO; carbon monoxide; DAMPs; danger-associated molecular patterns; DOCA; deoxycorticosterone acetate; dsRNA; double-stranded RNA; EDHF; endothelial-derived hyperpolarizing factor; ET
Keywords: Ontogeny; Thirst; Gestation; Isoproterenol; Hypertension; c-Fos; Renin-angiotensin-aldosterone system; ANG; angiotensin; AVP; arginine vasopressin; BP; blood pressure; CNS; central nervous system; DOCA; deoxycorticosterone; FLI; Fos-like immunoreactive; F
Keywords: comorbidities; HFpEF; murine model; AAC; ascending aortic constriction; BNP; brain natriuretic peptide; DOCA; deoxycorticosterone acetate; EF; ejection fraction; HF; heart failure; HFpEF; heart failure with preserved ejection fraction; HFrEF; heart failur
Keywords: (I-R); ischemia-reperfusion injury; IPC; ischemia preconditioning; ROS; reactive oxygen species; RNS; reactive nitrogen species; (ONOOâ); peroxynitrite; PI3K; phosphatidylinositol 3-kinase; PIP3; phosphatidyl-inositol 3,4,5-triphosphate; PIP2; phosp
Keywords: ACE; angiotensin-converting enzyme; CCR2; chemokine (C-C motif) receptor-2; CX3CR1; chemokine (C-X3-C motif) receptor-1; DOCA; deoxycorticosterone acetate; HIF; hypoxia-inducible factor; HSCs; hematopoietic stem cells; IL; interleukin; IRF5; interfe
Keywords: Atrial fibrillation; Atrial remodeling; Rapid atrial pacing; Porcine; DOCA; Arterial hypertension
Keywords: Aldo; aldosterone; Ang II; angiotensin II; AS; aldosterone synthase; AT1R; angiotensin II type 1 receptor; BBB; blood-brain barrier; BP; blood pressure; DEPC; diethylpyrocarbonate; DOCA; deoxycorticosterone acetate; EDTA; ethylenediaminetetraacetic acid
Keywords: ADH; adipic acid dihydrazide; AUNPs; gold nanoparticles; BA; butyric acid; CDDP; cisplatin; CHI; chitosane; CNTs; carbon nanotubes; CPT; camptothecin; CSCs; cancer stem cells; DiPhPE; diphytanoyl-sn-glycero-3-glycerophosphatidyl ethanolamine; DL; drug loa
Keywords: Histone deacetylases; Histone deacetylases inhibitors; Heart failure; Hypertrophy; DOCA; deoxycorticosterone acetate; HAT; histone acetyltransferases; HDAC; histone deacetylase; HDACi; histone deacetylase inhibitor; MEF2; myocyte enhancer factor-2; MITR;
Keywords: A; mitral inflow late filling velocity in pulse-wave Doppler; BDM; 2,3-butanedione monoxime; BH4; tetrahydrobiopterin; DOCA; deoxycorticosterone acetate; E; mitral inflow early filling velocity in pulse-wave Doppler; EF; ejection fraction; FS; fractional
Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration
Keywords: 2-AG; 2-arachidonoylglycerol; 4-HNE; 4-hydroxynonenal; 8-isoPGF2α; F2 -isoprostanes; 8-OHdG; 8-hydroxy-2'-deoxyguanosine; AA; arachidonic acid; AEA; N-arachidonoylethanolamine, anandamide; AM3506; 5-(4-hydroxyphenyl) pentanesulfonyl fluoride; Bach1; ba
Self-assembled nanocomplex of PEGylated protamine and heparin-suramin conjugate for accumulation at the tumor site
Keywords: PEG; polyethylene glycol; LHsura; low-molecular-weight heparin-suramin conjugate; TCA; taurocholate; DOCA; deoxycholic acid; FITC-dextran; fluorescein isothiocyanate-labeled dextran; NHS; N-hydroxylsuccinimide; EDAC; 1-ethyl-3-(3-dimethylaminopropyl) ca
Antihypertensive responses of vasoactive androgens in an in vivo experimental model of preeclampsia
Keywords: DHEA; dehydroepiandrosterone; TES; testosterone; 5α-DHT; 5α-dihydrotestosterone; 5β-DHT; 5β-dihydrotestosterone; BP; blood pressure; PT; treated pregnant; NP; normal pregnant; HR; heart rate; MAP; mean arterial blood pressure; Phe; phenylephrine; AR;
The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive and DOCA-salt hypertensive rats
Keywords: AEA; anandamide; ATGL; adipose triglyceride lipase; DAG; diacyloglycerol; DGAT; diglyceride acyltransferase; DMF; N,N-dimethylformamide; DOCA; 11-deoxycorticoterone acetate; ECS; endocannabinoid system; FAAH; fatty acid amide hydrolase; FABPpm; plasma mem
The role of interleukin-17A in the pathogenesis of kidney diseases
Keywords: Interleukin-17A; inflammation; kidney disease; AHR; aryl hydrocarbon receptor; AKI; acute kidney injury; ANCA; antineutrophil cytoplasmic antibody; APOE; apolipoprotein E; ASC; apoptosis-associated speck-like protein containing a carboxy-terminal CARD; Ct
Research reportHippocampal neurogenesis response: What can we expect from two different models of hypertension?
Keywords: CIH; chronic intermittent hypoxia; DG; dentate gyrus; DOCA; deoxycorticosterone acetate; DSS; Dahl salt-sensitive; IH; Intermittent hypoxia; OSA; obstructive sleep apnea; SGZ; subgranular zone; SHR; spontaneous hypertensive rats; SVZ; subventricular zone;
Protective effects of MCR-1329, a dual α1 and angII receptor antagonist, in mineralocorticoid-induced hypertension
Keywords: Angiotensin II; DOCA; Hypertension; Losartan; Prazosin
Evaluation of anti-hypertensive activity of Ulmus wallichiana extract and fraction in SHR, DOCA-salt- and L-NAME-induced hypertensive rats
Keywords: ACE; angiotensin converting enzyme; Ang II; angiotensin II; BF; butanolic fraction; BMD; bone mineral density; cGMP; cyclic guanosine monophosphate; DBP; diastolic blood pressure; DCFDA; 2â²,7â²-Dichlorodihydrofluorescein diacetate; DOCA; deoxycorticost
Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats
Keywords: Ach; acetylcholine; AEA; anandamide; BP; blood pressure; CRCs; concentration-response curves; DMF; N,N-Dimethylformamide; DMSO; dimethyl sulfoxide; DOCA; deoxycorticosterone acetate; FAAH; fatty acid amide hydrolase; HÂ +Â E; hematoxylin and eosin; i.p.;
Valsartan inclusion by methyl-β-cyclodextrin: Thermodynamics, molecular modelling, Tween 80 effect and evaluation
Keywords: VAL; valsartan; M-β-CD; methyl-β-cyclodextrin; DOCA; deoxycorticosterone acetate; HP-β-CD; hydroxypropyl-β-cyclodextrin; DSC; differential scanning calorimeter; XRPD; X-ray powder diffractrometry; FT-IR; Fourier transform infrared; NMR; nuclear magnet
Towards a novel process concept for the hydroformylation of higher alkenes: Mini-plant operation strategies via model development and optimal experimental design
Keywords: bic; bicontinuous phase; cat; catalyst; doce; 1-dodecene; doca; dodecane; GGW; equilibrium; Hyd; hydration to dodecane; HyfoA/B; hydroformylation to n-tridecanal (A) or iso-tridecanal (B); Iso; isomerization; IsoA/B; isomerization to iso-dodecene (A) or 1
Involvement of central cholinergic mechanisms on sodium intake induced by gabaergic activation of the lateral parabrachial nucleus
Keywords: ANG II; angiotensin II; CAP; captopril; CCK; cholecystokinin; CRF; corticotrophin release factor; DOCA; deoxycorticosterone acetate; FURO; furosemide; i.c.v.; intracerebroventricular; LPBN; lateral parabrachial nucleus; LV; lateral ventricle; NTS; nucleus
Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats
Keywords: Diosmin; Antioxidant; DOCA; Nitric oxide;
Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension
Keywords: Ang II; angiotensin II; DAPI; 4,6-diamidino-2-phenylindole dichlorohydrate; DHE; dihydroethidium; DOCA; deoxycorticosterone acetate; DPI; diphenylene iodonium; eNOS; endothelial nitric oxide synthase; ET-1; endothelin-1; GCLC; γ-glutamylcysteine syntheta
Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: A biochemical and histopathological evaluation
Keywords: DOCA; deoxycorticosterone acetate; UNX; uninephrectomized; CVD; cardiovascular diseases; WHO; world health organisation; DMF; dimethyl formamide; TBARS; thiobarbituric acid reactive substances; TBA; thiobarbituric acid; TCA; trichloro acetic acid; HCL; hy
Vasorelaxant and antihypertensive effect of Cocos nucifera Linn. endocarp on isolated rat thoracic aorta and DOCA salt-induced hypertensive rats
Keywords: CNE; Cocos nucifera Linn. ethanolic extract; NO; nitric oxide; GC; guanylate cyclase; NE; norepinephrine; PhE; phenylephrine hydrochloride; l-NNA; NG-nitro-l-arginine; ODQ; 1H-[1,2,4]-oxadiazolo-[4,3-A]-quinoxalin-1-one; Ca2+; calcium ion; cAMP; cyclic ad
Cognitive, Behavioral, and Systems NeuroscienceResearch PaperImportance of central AT1 receptors for sodium intake induced by GABAergic activation of the lateral parabrachial nucleus
Keywords: sodium appetite; parabrachial nucleus; angiotensin II; satiety; GABA; ANG II; angiotensin II; b. wt.; body weight; CAP; captopril; CCK; cholecystokinin; CRF; corticotrophin release factor; DOCA; deoxycorticosterone acetate; FURO; furosemide; Los; losartan
Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension
Keywords: 20-hydroxyeicosatetraenoic acid; PPARα; hypertension; DOCA
Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction
Keywords: ACh; acetylcholine; ANOVA; analysis of variance; CMC; carboxy methyl cellulose; DAQ B1; demethylasterriquinone B1; DMSO; dimethyl sulfoxide; DOCA; desoxycortisone acetate; eNOS; endothelial nitric oxide synthase; MABP; mean arterial blood pressure; NBT; n
The effect of hypertension on serum nitric oxide and vascular endothelial growth factor concentrations. A study in DOCA-Salt hypertensive ovariectomized rats
Keywords: CVD; CardioVascular Disease; NO; Nitric Oxide; VEGF; Vascular Endothelial Growth Factor; DOCA; Deoxy Corticosterone Acetate.; Hypertension; Nitric oxide; Vascular endothelial growth factor;
Renal atrial natriuretic peptide receptors binding properties and function are resistant to DOCA–salt-induced hypertension in rats
Keywords: ANP, atrial natriuretic peptide; BNP, brain natriuretic peptide; CNP, C-type natriuretic peptide; NPR, natriuretic peptide receptor; DOCA, deoxycorticosterone acetate; SHR, spontaneously hypertensive rats.NPR-A; NPR-C; Renal glomeruli; Hypertension; DOCA;
Role of Endothelin in the Pathogenesis of Hypertension
Keywords: Ang II; angiotensin II; AVP; arginine vasopressin; DOCA; desoxycorticosterone acetate; DS; Dahl salt-sensitive; ECE; ET-converting enzyme; ET; endothelin; GFR; glomerular filtration rate; IMCD; inner medullary collecting duct; IP3; inositol triphosphate;
Animal models of hypertension: An overview
Keywords: 2K1C; 2-kidneys, 1-clip; ACE; angiotensin-converting enzyme; AngII; angiotensin II; ANP; atrial natriuretic peptide; AR; adrenergic receptors; AT1; angiotensin II type 1 receptor; DOCA; deoxycorticosterone-acetate; eNOS; endothelial nitric oxide synthase;